OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dapagliflozin ameliorates hepatic steatosis via suppressing LXRα-mediated synthesis of lipids and bile acids
Zijie Jin, Ruotong Yin, Yan Yuan, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116167-116167
Closed Access | Times Cited: 8
Zijie Jin, Ruotong Yin, Yan Yuan, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116167-116167
Closed Access | Times Cited: 8
Showing 8 citing articles:
Dapagliflozin modulates hepatic lipid metabolism through the proprotein convertase subtilisin/kexin type 9/low density lipoprotein receptor pathway
Fengyuan Lu, En Li, Yifeng Gao, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Fengyuan Lu, En Li, Yifeng Gao, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis
Chi Zhang, X Yang, Yi Xue, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
Chi Zhang, X Yang, Yi Xue, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
Impact of 1,2-Bis (2,4,6-Tribromophenoxy) Ethane on Liver Metabolism and Intestinal Health in Zebrafish: Role of the Liver X Receptor
Biran Zhu, Qianqian Zhang, Xianglin Chen, et al.
Environmental Science & Technology (2025)
Closed Access
Biran Zhu, Qianqian Zhang, Xianglin Chen, et al.
Environmental Science & Technology (2025)
Closed Access
Intestinal FXR deficiency induces dysregulation of xanthine oxidase and accounts for sex difference in hyperuricemia
Ruixia Bao, Beibei Chen, Alexander Wang, et al.
Free Radical Biology and Medicine (2024)
Closed Access | Times Cited: 3
Ruixia Bao, Beibei Chen, Alexander Wang, et al.
Free Radical Biology and Medicine (2024)
Closed Access | Times Cited: 3
Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial
Meng‐Tzu Weng, Po‐Jen Yang, Pan-Fu Liu, et al.
Hepatology International (2024)
Closed Access | Times Cited: 2
Meng‐Tzu Weng, Po‐Jen Yang, Pan-Fu Liu, et al.
Hepatology International (2024)
Closed Access | Times Cited: 2
Retrospective Longitudinal Observational Study on the Long-Term Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetic Japanese Patients
Hisayuki Katsuyama, Seiichi Horinaka, Mariko Hakoshima, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4929-4929
Open Access | Times Cited: 1
Hisayuki Katsuyama, Seiichi Horinaka, Mariko Hakoshima, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4929-4929
Open Access | Times Cited: 1
Complex actions of sodium glucose transporter-2 inhibitors on lipids, calcific atherosclerosis, and bone density
Stuti Pradhan, Sophia Kalanski, Yin Tintut, et al.
Current Opinion in Lipidology (2024) Vol. 35, Iss. 5, pp. 253-257
Closed Access
Stuti Pradhan, Sophia Kalanski, Yin Tintut, et al.
Current Opinion in Lipidology (2024) Vol. 35, Iss. 5, pp. 253-257
Closed Access
The cellular and molecular mechanisms mediating the protective effects of sodium–glucose linked transporter 2 inhibitors against metabolic dysfunction‐associated fatty liver disease
Na Ao, Jian Du, Shi Jin, et al.
Diabetes Obesity and Metabolism (2024) Vol. 27, Iss. 2, pp. 457-467
Closed Access
Na Ao, Jian Du, Shi Jin, et al.
Diabetes Obesity and Metabolism (2024) Vol. 27, Iss. 2, pp. 457-467
Closed Access
